Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Depressed fish could help in the search for new drug treatments

06.08.2013
Antidepressant normalises the behaviour of zebrafish with a defective stress hormone receptor

Chronic stress can lead to depression and anxiety in humans. Scientists working with Herwig Baier, Director at the Max Planck Institute of Neurobiology in Martinsried, recently discovered a very similar link in fish. Normally, the stress hormone cortisol helps fish, as in humans, to regulate stress.


The zebrafish (Danio rerio) is a popular model organism for many questions in the field of genetics and developmental biology.
© MPI f. Neurobiology


Zebrafish with a mutation in the glucocorticoid receptor exhibit passive behaviour in a stressful situation. The behaviour returns to normal with a commercial antidepressant in the water. The findings demonstrate a significant correlation between stress regulation and mood disorders, one which evidently plays a central role in humans, too.
© Max Planck Institute of Neurobiology / Schorner

Fish that lack the receptor for cortisol as a result of a genetic mutation exhibited a consistently high level of stress. They were unable to adapt to a new and unfamiliar situation. The fishes’ behaviour returned to normal when an antidepressant was added to the water. These findings demonstrate a direct causal link between chronic stress and behavioural changes which resemble depression. The findings could also open the door to an effective search for new drugs to treat psychiatric disorders.

In stressful situations, the body releases hormones in order to ready itself for a fight or flight reaction. But it is equally important for the hormone level to return to normal after a certain time. If that does not happen, chronic stress can result, a condition that is linked to depression and anxiety, among other things. Whether stress is a trigger or merely a side effect of such affective disorders remains unclear.

The indication of a causal relationship between stress and depression comes from totally unexpected quarters. An international team led by Herwig Baierfrom the Max Planck Institute of Neurobiology in Martinsried and the University of California in San Francisco observed that zebrafish suffering from chronic stress as a result of a genetic mutation showed signs of depression in behavioural tests. The zebrafish is a popular model organism for biological and medical research. So far, however, it has not been an obvious research object for the study of psychiatric disorders. This may be about to change.

"These mutant fish behaved very strangely when we moved them to a new aquarium," reports Herwig Baier. All animals experience stress upon moving to an unfamiliar environment. Being separated from members of their own species places the fish under added pressure. Zebrafish initially act withdrawn in this situation and swim around very hesitantly in the first few minutes. But ultimately, curiosity prevails, and they begin to investigate their new tank. However, the fish with the mutation had a particularly strong reaction to the isolation: they sank to the bottom of the tank and stayed completely still. They took an exceptionally long time to get used to the new environment.

An analysis of these "lethargic" fish showed that they had an extremely elevated concentration of the stress hormones cortisol, CRH and ACTH. "We therefore postulated that these fish were suffering from chronic stress and were exhibiting certain aspects of depressive or perhaps hyper-anxious behaviour," says Baier. To put this assumption to the test, the scientists added the antidepressant fluoxetine (marketed under the trade name Prozac, among others) to the water. Shortly afterwards, the fish's behaviour returned to normal.

What was it that made these fish so different? The scientists uncovered a mutation in the glucocorticoid receptor, which is present in almost all of the body's cells and which binds the hormone cortisol. Normally, when cortisol is bound to this receptor it restricts the release of the stress hormones CRH and ACTH. It is this regulating mechanism that enables humans and many animal species to cope with stress. In the type of fish the scientists examined, however, the glucocorticoid receptor was unable to function, and so the level of stress hormones remained high.

"Although there are a whole range of drugs available for depression, no one yet knows what the relationship is between their effect and the stress hormones," explains Herwig Baier. "Our findings provide the first evidence of a possible connection." Understanding the molecular and neurobiological relationships between stress regulation and affective disorders is important in the search for new treatments and drugs. The scientists' discovery is therefore also of interest to the pharmaceutical industry, given that the zebrafish could turn out to be a good model organism for a large-scale screen for new drugs.

Contact

Prof. Dr. Herwig Baier
Max Planck Institute of Neurobiology, Martinsried
Phone: +49 89 8578-3200
Fax: +49 89 8578-3208
Email: hbaier@­neuro.mpg.de
Dr. Stefanie Merker
Max Planck Institute of Neurobiology, Martinsried
Phone: +49 89 8578-3514
Email: merker@­neuro.mpg.de
Original publication
L Ziv, A Muto, PJ Schoonheim, SH Meijsing, D Strasser, HA Ingraham, MJM Schaaf, KR Yamamoto & H Baier
An affective disorder in zebrafish with mutation of the glucocorticoid receptor
Molecular Psychiatry (2013) 18, 681--691; doi:10.1038/mp.2012.64; June 2013

Prof. Dr. Herwig Baier | EurekAlert!
Further information:
http://www.mpg.de/7491503/fish-depression

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Predicting unpredictability: Information theory offers new way to read ice cores

07.12.2016 | Earth Sciences

Sea ice hit record lows in November

07.12.2016 | Earth Sciences

New material could lead to erasable and rewriteable optical chips

07.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>